Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease

The Cross Sectional Study to Investigate the Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease and Healthy Controls

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02176811

Enrollment

Registered

2014-06-27

Start date

2009-06-30

Completion date

2014-02-28

Last updated

2014-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic Fatty Liver Disease

Keywords

Non-alcoholic Fatty Liver Disease, Betatrophin

Brief summary

The study searched for answers to two questions: 1-What are the plasma betatrophin levels in subjects with non-alcoholic fatty liver disease and healthy controls. 2\. Is there any relationship between plasma betatropin levels and different stage of non-alcoholic fatty liver disease 2.Is there any relationship between plasma betatropin levels and metabolic parameters in subjects with non-alcoholic fatty liver disease.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

MALE

Age

20 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients with biopsy proven non-alcoholic fatty liver disease

Exclusion criteria

* Taking any drugs * \>20 gr/day alcohol consumption * chronic metabolic diseases * morbid obesity

Design outcomes

Primary

Measure	Time frame
Plasma betatrophin levels in subjects with non-alcoholic fatty liver disease and healthy controls.	6 months

Countries

Turkey (Türkiye)

Outcome results